# SarCNU in Treating Patients With Recurrent Malignant Glioma

> **NCT00036660** · PHASE2 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 10 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** SarCNU

## Key facts

- **NCT ID:** NCT00036660
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01-10
- **Primary completion:** 2003-04-15
- **Final completion:** 2008-09-22
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00036660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00036660, "SarCNU in Treating Patients With Recurrent Malignant Glioma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00036660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*